Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.

Aviles H, Stiles J, O'Donnell P, Orshal J, Leid J, Sonnenfeld G, Monroy F.

J Parasitol. 2008 Dec;94(6):1282-8. doi: 10.1645/GE-1309.1.

PMID:
19127964
2.

Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.

Schlüter D, Kwok LY, Lütjen S, Soltek S, Hoffmann S, Körner H, Deckert M.

J Immunol. 2003 Jun 15;170(12):6172-82.

3.
4.

MyD88 is crucial for the development of a protective CNS immune response to Toxoplasma gondii infection.

Torres M, Guiton R, Lacroix-Lamandé S, Ryffel B, Leman S, Dimier-Poisson I.

J Neuroinflammation. 2013 Feb 1;10:19. doi: 10.1186/1742-2094-10-19.

5.

Kinetic analysis of cytokines, chemokines, chemokine receptors and adhesion molecules in murine ocular toxoplasmosis.

Kikumura A, Ishikawa T, Norose K.

Br J Ophthalmol. 2012 Sep;96(9):1259-67. doi: 10.1136/bjophthalmol-2012-301490. Epub 2012 Jul 11.

PMID:
22790439
6.
9.

Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii.

Burke JM, Roberts CW, Hunter CA, Murray M, Alexander J.

Parasite Immunol. 1994 Jun;16(6):305-14.

PMID:
7970867
10.
11.

Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.

Zorgi NE, Galisteo AJ Jr, Sato MN, do Nascimento N, de Andrade HF Jr.

Med Microbiol Immunol. 2016 Aug;205(4):297-314. doi: 10.1007/s00430-015-0447-5. Epub 2016 Jan 5.

PMID:
26732075
12.

Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis.

Brown CR, Hunter CA, Estes RG, Beckmann E, Forman J, David C, Remington JS, McLeod R.

Immunology. 1995 Jul;85(3):419-28.

13.

Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.

Zhao Y, Huang B, Huang S, Zheng H, Li YQ, Lun ZR, Shen J, Wang Y, Kasper LH, Lu F.

Parasitol Res. 2013 Sep;112(9):3151-60. doi: 10.1007/s00436-013-3491-3. Epub 2013 Jun 20.

PMID:
23783399
14.
15.

DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.

Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ.

Vaccine. 2013 Dec 16;31(52):6225-31. doi: 10.1016/j.vaccine.2013.10.034. Epub 2013 Oct 31.

PMID:
24183979
16.

Different roles for interleukin-4 during the course of Toxoplasma gondii infection.

Roberts CW, Ferguson DJ, Jebbari H, Satoskar A, Bluethmann H, Alexander J.

Infect Immun. 1996 Mar;64(3):897-904.

17.

Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma.

Strack A, Asensio VC, Campbell IL, Schlüter D, Deckert M.

Acta Neuropathol. 2002 May;103(5):458-68. Epub 2002 Jan 31.

PMID:
11935261
18.
19.

Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection.

Singh J, Graniello C, Ni Y, Payne L, Sa Q, Hester J, Shelton BJ, Suzuki Y.

Microbes Infect. 2010 Dec;12(14-15):1252-7. doi: 10.1016/j.micinf.2010.07.016. Epub 2010 Aug 11.

20.

Functional and quantitative analysis of splenic T cell immune responses following oral toxoplasma gondii infection in mice.

Lee YH, Channon JY, Matsuura T, Schwartzman JD, Shin DW, Kasper LH.

Exp Parasitol. 1999 Mar;91(3):212-21.

PMID:
10072323

Supplemental Content

Support Center